MARAVAI LIFESCIENCES HOLDINGS, INC.
For the period ended Dec 31, 2024. Filed Mar 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 18, 2025
MRVI$7.86-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive (Loss) Income
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net (loss) income | $(259,622) | $(138,375) | $490,663 |
| Comprehensive (loss) income attributable to non-controlling interests | (114,776) | (19,346) | 270,458 |
| Total comprehensive (loss) income attributable to Maravai LifeSciences Holdings, Inc. | $(144,846) | $(119,029) | $220,205 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.